USPTO serial 50191263
BGBX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with BGBX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
New York, NY, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lori P. Hager
Lori P. Hager Kyberia Legal88 S Finley Avenue 2nd Fl. Suite ABasking Ridge, NJ 07920United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Providing on-line non-downloadable software for predictive analytics in the field of pharmaceuticals; Providing on-line non-downloadable software for managing, accessing and sharing information and data related to performance metrics; Providing on-line non-downloadable software for analyze and select of algorithms for use in predictive analytics in the field of pharmaceuticals; Providing on-line non-downloadable software for creating advertising layout; Providing on-line non-downloadable software for compiling and organizing business intelligence; Software as a service (SAAS) services, namely, hosting software for use by others for business data analysis, in the field of pharmaceuticals; Software as a service (SAAS) services, namely, hosting software for use by others for tracking performance metrics, data visualizations, and predictive analytics in the field of pharmaceuticals, and providing reports; Software as a service (SAAS) services featuring software for tracking performance metrics, data visualizations, and predictive analytics in the field of pharmaceuticals, and providing reports; Software as a service (SAAS) services featuring software for use in managing, developing, analyzing, summarizing, editing, and sorting data stored in computer database; Software as a service (SAAS) services featuring software for business data analysis, in the field of pharmaceuticals; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for managing, developing, analyzing, summarizing, editing, and sorting data stored in computer databases in the field of pharmaceuticals; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for generating business analysis reports; Platform as a service (PAAS) featuring computer software platforms for tracking performance metrics, data visualizations, and predictive analytics in the field of pharmaceuticals and providing reports and alerts concerning such performance; Platform as a service (PAAS) featuring computer software platforms for information processing, namely, software for managing, developing, analyzing, summarizing, editing, and sorting data stored in computer databases; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for tracking performance metrics, data visualizations, and predictive analytics in the field of pharmaceuticals, and providing reports; Computer services in the nature of customized web pages and other data feed formats featuring user-defined information; Platform as a service (PAAS) featuring computer software platforms for business data analysis and predictive analytics, in the field of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 30, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 30, 2026 | NWAP | NEW APPLICATION ENTERED | — |